Table 1.
Characteristics of patients and controls.
| Patients n=17 | Controls n=17 | |
|---|---|---|
| Demographics | ||
| Age, year (median, range) | 64 (40–80) | 60 (37–69) |
| Men/women | 11/6 | 10/7 |
| Cardiac Risk Factors | ||
| Diabetes | 6 | 4 |
| Current/former smoker | 10 | 2 |
| Hyperlipidemia | 10 | 4 |
| Hypertension | 8 | 4 |
| Syntax score (mean ± SD) | 14.7 ± 9.1 | |
| EST results | ||
| Chest pain | 3 | |
| ST-depression, mv > 0.2 | 14 | |
| Duration, min (median, range) | 6.8 [6–9] | 8.9 [9–18] |
| Workload, METa (median, range) | 6.9 [6–11] | 8.9 [7–14] |
| Workload, Watt (median, range) | 125 [90–150] | 135 [90–180] |
| Peak HRb (median, range) | 138 [120–150] | 145 [130–165] |
| Peak SBPc (median, range) | 188 [180–220] | 184 [180–250] |
| Treatment | ||
| Ticagrelor | 4 (26%) | |
| Clopidogrel | 11 (74%) | |
| Aspirin | 8 (47%) | |
| Statins | 7 (41%) | 4 (26%) |
| Ezetimibe | 10 (58%) | |
| Beta-blocker | 1 (6%) | 4 (26%) |
| Renin-angiotensin system inhibitor | 4 (26%) | |
| Esomeprazole | 11 (74%) | 4 (26%) |
| Metformin | 6 (40%) | |
| Extent of coronary disease | ||
| – 1 vessel | 9 | |
| – 2 vessel | 5 | |
| – 3 vessel | 3 | |
| – 0 vessel | 17 | |
| Coronary vessel narrowed | ||
| – Left-main | 1 | |
| – Left-anterior descending | 9 | |
| – Left-circumflex | 9 | |
| – Right | 8 | |
a
MET: mean metabolic equivalents of task level.
b
HR: heart rate.
c
SBP: systolic blood pressure.